BioCentury

7:00 AM GMT, Sep 20, 2010
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

RLY5016: Phase IIb data

The double-blind, international Phase IIb PEARL-HF trial in 104 patients already receiving >=1 renin-angiotensin-aldosterone system (RAAS)

Read the full 169 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.